Cresco Labs Inc.
CRLBF
$0.80
-$0.02-2.28%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 651.13M | 641.42M | 655.85M | 670.20M | 685.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 651.13M | 641.42M | 655.85M | 670.20M | 685.07M |
| Cost of Revenue | 326.06M | 320.03M | 331.28M | 344.93M | 345.72M |
| Gross Profit | 325.08M | 321.39M | 324.57M | 325.27M | 339.35M |
| SG&A Expenses | 239.95M | 226.75M | 227.28M | 226.01M | 231.55M |
| Depreciation & Amortization | 22.48M | 19.94M | 20.18M | 20.67M | 20.74M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 588.48M | 566.72M | 578.73M | 591.61M | 598.01M |
| Operating Income | 62.65M | 74.70M | 77.11M | 78.59M | 87.06M |
| Income Before Tax | -103.64M | -97.30M | -95.42M | -5.22M | 16.20M |
| Income Tax Expenses | 8.92M | 44.53M | 44.62M | 45.44M | 52.58M |
| Earnings from Continuing Operations | -112.56 | -141.82 | -140.04 | -50.66 | -36.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.64M | 7.78M | 4.64M | -1.54M | -9.30M |
| Net Income | -100.92M | -134.05M | -135.41M | -52.19M | -45.68M |
| EBIT | 62.65M | 74.70M | 77.11M | 78.59M | 87.06M |
| EBITDA | 111.14M | 122.72M | 125.83M | 130.45M | 141.00M |
| EPS Basic | -0.28 | -0.37 | -0.38 | -0.15 | -0.13 |
| Normalized Basic EPS | 0.06 | 0.07 | 0.06 | 0.04 | 0.03 |
| EPS Diluted | -0.29 | -0.38 | -0.38 | -0.15 | -0.13 |
| Normalized Diluted EPS | 0.06 | 0.07 | 0.06 | 0.04 | 0.03 |
| Average Basic Shares Outstanding | 1.45B | 1.43B | 1.42B | 1.41B | 1.40B |
| Average Diluted Shares Outstanding | 1.55B | 1.43B | 1.42B | 1.41B | 1.40B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |